Global Pharmaceuticals & Biotech Big Green Snowflakes

South American Gold

Market Cap: US$1.3k

South American Gold Corp. is focused on becoming the premiere provider of value added products and services for the cultivation and processing of cannabis for the South American medical and recreational markets with an initial focus on the Uruguayan market.

Mymetics

Market Cap: US$45.0

Engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.

FluoroPharma Medical

Market Cap: US$27.0

A biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States.

Lattice Biologics

Market Cap: US$128.0

A biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide.

Comera Life Sciences Holdings

Market Cap: US$6.1k

A preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform.

Vidac Pharma Holding

Market Cap: €25.3m

An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.

Healthtech Solutions

Market Cap: US$10.7k

Through its subsidiaries, operates as a life sciences company.

Myrexis

Market Cap: US$6.9k

Focuses on identifying, evaluating, and making financial investments in life sciences assets.

Immage Biotherapeutics

Market Cap: US$151.0

Does not have significant business operations.

AItheNutrigene

Market Cap: ₩5.2b

Provides test-detection solutions for early detection and and prevention of diseases.

Emerging World Pharma

Market Cap: US$119.0

Invests in generic based pharmaceutical companies manufacturing within developing nations.

Bio Preventive Medicine

Market Cap: NT$1.2b

Bio Preventive Medicine Corp, a clinical-staged biotech company, focusing on early detection and prevention of diseases.

Invites Biocore

Market Cap: ₩27.7b

Provides bioanalytical and central lab services in South Korea and internationally.

Genotech

Market Cap: ₩5.6b

Provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally.

Cronex.Co.Ltd

Market Cap: ₩1.8b

Engages in the research and development of medicines and raw materials for medical research.

MegaPro Biomedical

Market Cap: NT$1.1b

A biotech company, focuses on the development of nano drugs.

Angiolab

Market Cap: ₩13.7b

A biotechnology company, develops medicine with angiogenesis inhibitors for treating angiogenesis-related diseases.

MEDIZEN HUMANCARE

Market Cap: ₩4.1b

A research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally.

Steminent Biotherapeutics

Market Cap: NT$2.7b

Operates as a biopharmaceutical company.

NovMetaPharma

Market Cap: ₩178.7b

Engages in the development and sale of drugs to treat metabolic diseases in South Korea.

NPTLtd

Market Cap: JP¥5.8b

Engages in clinical development of new drugs and treatments for personalized medicines.

GlobeImmune

Market Cap: US$575.0

A biopharmaceutical company, focuses on developing therapeutic products for cancer and infectious diseases based on proprietary Tarmogen platform.

Abattis Bioceuticals

Market Cap: US$12.9k

Operates as a life sciences and biotechnology company in Canada.

Emergent Health

Market Cap: US$426.0

Develops and sells regenerative medicine, neutraceuticals, and phytonutritionals.

Scopus BioPharma

Market Cap: US$12.6k

A clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs.

Protect Pharmaceutical

Market Cap: US$27.6m

Primarily focuses on crop farming and agricultural businesses.

AVVAA World Health Care Products

Market Cap: US$3.3m

Provides natural and therapeutic skin care products worldwide.

Halberd

Market Cap: US$1.5m

A biotech company, develops treatments for neurodegenerative diseases.

Vaxxinity

Market Cap: US$5.5m

A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.

Endexx

Market Cap: US$3.1m

Engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market.

Marijuana Company of America

Market Cap: US$22.1k

Develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand name in the United States.

Nabriva Therapeutics

Market Cap: US$323.0

A biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections.

Access-Power

Market Cap: US$903.0k

A medical marijuana clone company, manufactures and distributes medical marijuana clone products.

Chalice Brands

Market Cap: US$8.4k

Engages in the retail, production, processing, wholesale, and distribution of cannabis products.

MabCure

Market Cap: US$78.1k

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer.

Stem Holdings

Market Cap: US$6.0

Does not have significant operations.